VRS
VNDA icon

Virginia Retirement Systems’s Vanda Pharmaceuticals VNDA Stock Holding History

Virginia Retirement Systems’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.07M Buy
248,300
+195,900
+374% +$1.09M 0.01% 496
2023
Q2 		$345K Buy
52,400
+1,900
+4% +$12.2K ﹤0.01% 810
2023
Q1 		$343K Buy
50,500
+11,800
+30% +$83K ﹤0.01% 844
2022
Q4 		$286K Buy
38,700
+3,200
+9% +$31.2K ﹤0.01% 983
2022
Q3 		$351K Buy
+35,500
New +$375K ﹤0.01% 907
2022
Q1 		$253K Sell
22,400
-5,700
-20% -$74.9K ﹤0.01% 1010
2021
Q4 		$441 Sell
28,100
-9,700
-26% -$169K ﹤0.01% 889
2021
Q3 		$648K Sell
37,800
-11,400
-23% -$200K 0.01% 742
2021
Q2 		$1.06M Sell
49,200
-800
-2% -$14.3K 0.01% 627
2021
Q1 		$751K Sell
50,000
-4,100
-8% -$66.4K 0.01% 756
2020
Q4 		$711K Buy
54,100
+27,200
+101% +$327K 0.01% 721
2020
Q3 		$260K Buy
+26,900
New +$288K ﹤0.01% 971
2019
Q1 		– Sell
-66,000
Closed -$1.73M – 1125
2018
Q4 		$1.73M Buy
66,000
+28,100
+74% +$661K 0.02% 430
2018
Q3 		$870K Sell
37,900
-1,700
-4% -$34.7K 0.01% 752
2018
Q2 		$754K Buy
+39,600
New +$662K 0.01% 778
2017
Q3 		– Sell
-11,200
Closed -$183K – 1128
2017
Q2 		$183K Sell
11,200
-2,600
-19% -$37.5K ﹤0.01% 1013
2017
Q1 		$193K Buy
+13,800
New +$197K ﹤0.01% 1076
2016
Q4 		– Sell
-21,700
Closed -$361K – 1040
2016
Q3 		$361K Buy
+21,700
New +$292K 0.01% 781
2015
Q2 		– Sell
-24,100
Closed -$224K – 1040
2015
Q1 		$224K Buy
+24,100
New +$272K ﹤0.01% 923

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virginia Retirement Systems's VNDA Position: Q3 2023 in Review

Virginia Retirement Systems increased its Vanda Pharmaceuticals (VNDA) stake by 374% in Q3 2023, buying an estimated $1.09M and bringing the position to 248,300 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #496.

Virginia Retirement Systems first reported a position in VNDA in Q1 2015 and has held it in 19 quarters since. The position peaked at $1.73M in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Virginia Retirement Systems held 248,300 shares of Vanda Pharmaceuticals worth $1.07M as of Q3 2023.
  • Virginia Retirement Systems bought 195,900 Vanda Pharmaceuticals shares in Q3 2023, an estimated $1.09M.
  • Vanda Pharmaceuticals made up 0.01% of Virginia Retirement Systems's portfolio in Q3 2023, its #496 holding.
  • Virginia Retirement Systems first reported a position in Vanda Pharmaceuticals in Q1 2015 and has held it in 19 quarters since.
  • Virginia Retirement Systems's Vanda Pharmaceuticals position peaked at $1.73M in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.